Glossary
October 20, 2026

A Startup Says It Treated a Patient's Drug-Resistant Infection With Bacteria-Killing Viruses Designed by AI, but the Results Aren't In Yet

Radical Numerics, an AI startup, says a patient with an infection that no antibiotic could cure has been given viruses its AI program redesigned to kill that patient's bacteria. The company calls it the first medical use of AI-designed viruses of this kind. Nobody knows yet whether it worked, and the claim hasn't been reviewed by outside scientists.

A startup called Radical Numerics announced today that viruses designed with the help of its AI program have been given to a patient for the first time.

The viruses are phages: viruses that infect bacteria, not people. Doctors have used them for about a century to fight infections, and interest has grown as more bacteria learn to survive antibiotics. The company cites estimates that drug-resistant infections were linked to about 4.7 million deaths in 2021. The catch with phages is that each one only attacks certain strains of bacteria, so doctors have to hunt for one that matches a patient's infection, which can take a long time.

The patient in this case has a serious E. coli infection that resists every available antibiotic and every phage doctors tried. The company's AI program, called Omnii-1, learned from the genetic code of many phages and the bacteria they attack. Given details of the patient's bacteria, it redesigned the parts a well-known phage uses to grab onto its target, like changing the shape of a key. The company says a mix including its redesigned phages killed the patient's bacteria in a lab dish, safety tests were done, and the U.S. Food and Drug Administration authorized the treatment under a special exception for patients with no other options.

That's where the facts stop. The company won't share anything about the patient or the doctors, citing privacy, and hasn't said how the patient is doing. Phage treatment can take days or weeks, and doctors usually watch for months in case the infection comes back. Its write-up is posted on its own website and hasn't been reviewed by outside scientists. The company itself says one patient "cannot establish general safety or efficacy."

Outside experts are waiting to see. "If it works, that's incredible," Michael Baym, a Harvard microbiologist not involved in the work, told The New York Times. But he said he would reserve judgment until the treatment is finished, adding, "My impulse is to be skeptical." The company's chief executive, Eric Nguyen, says it hopes to publish in a scientific journal and to eventually design phages for a patient in days.

Sources

  1. Radical Numerics — First AI-generated phages to reach a human patient with Omnii-1radicalnumerics.ai · primary
  2. The New York Times (via GV Wire) — Startup claims to use AI-created viruses to treat a patientgvwire.com
Follow the timeline
Get an email when new entries are added.
© 2026 Sugarpine